Open AccessBowel Perforation in a Patient with Hepatocellular Carcinoma during Lenvatinib Treatment
Author(s) -
Mizokami Ken,
Watanabe Akiko,
Yamaguchi Eriko,
Saito Akira
Publication year - 2022
Publication title -
case reports in gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.247
H-Index - 18
ISSN - 1662-0631
DOI - 10.1159/000525569
Subject(s) - single case
We present a case of severe bowel perforation during lenvatinib treatment for advanced hepatocellular carcinoma. Although the Hartmann’s procedure was performed, the patient died 48 h after the operation. The histopathological findings suggested that lenvatinib was involved in the etiology of bowel perforation in this case.